The global market for Regenerative Biologic Injectables was valued at US$ 20154 million in the year 2024 and is projected to reach a revised size of US$ 40806 million by 2031, growing at a CAGR of 10.7% during the forecast period.

Regenerative Biologic Injectables Market

Regenerative Biologic Injectables are injectable therapeutic formulations developed based on bioactive materials and regenerative medicine principles, primarily designed to stimulate the body’s intrinsic repair and regeneration mechanisms to restore damaged soft tissues, cartilage, nerves, or skin. These products typically contain growth factors, extracellular matrix components, platelet-rich plasma (PRP), stem cell derivatives, or bioactive peptides. Through precise injection, they act directly on diseased or degenerative tissues, promoting local cell proliferation and matrix remodeling. In recent years, with the convergence of biomaterials, cell therapy, and regenerative technologies, Regenerative Biologic Injectables have been widely applied in orthopedics (such as osteoarthritis and cartilage repair), aesthetic medicine (skin regeneration and scar treatment), sports medicine, and chronic wound care—emerging as one of the fastest-growing segments in regenerative healthcare.The average gross profit margin of this product is 75%.

The rapid advancement of regenerative medicine, coupled with global population aging, is driving strong demand for regenerative biologic injectables. As soft tissue injuries, joint degeneration, skin aging, and wound healing disorders become more prevalent, minimally invasive injectable therapies are gaining traction as effective clinical alternatives. Breakthroughs in stem cell-derived materials, bioactive proteins, and extracellular matrix technologies have improved both the safety and durability of these injectables. Furthermore, regulatory relaxations—such as the U.S. FDA’s HCT/P framework and Japan’s Regenerative Medicine Act—are creating favorable conditions for commercialization and clinical adoption.

Despite promising growth prospects, the regenerative biologic injectables industry faces substantial technical and regulatory challenges. Manufacturing involves stringent control of bioactive compound stability and aseptic processing, while clinical efficacy may vary widely due to individual and source-related factors. Regulatory pathways for biologic and regenerative products remain inconsistent across regions, leading to lengthy approval timelines and ethical debates, particularly for stem cell-derived formulations. Moreover, high manufacturing and clinical trial costs hinder market entry and scalability for smaller manufacturers.

Clinically, orthopedic and sports medicine sectors are increasingly adopting PRP and growth factor-based injectables for cartilage and tendon regeneration. The aesthetic medicine market is expanding rapidly, with collagen-inducing and exosome-based injectables being widely used for skin rejuvenation, scar improvement, and anti-aging therapies. Chronic wound and ulcer care represent emerging application areas, as hospitals and clinics increasingly integrate biologic-based injectable repair solutions. Moving forward, personalized and precision regenerative therapies are expected to define the next phase of market evolution.

The upstream materials for regenerative biologic injectables primarily include blood-derived components (such as PRP), collagen from human or animal sources, hyaluronic acid, bioactive peptides, stem cell exosomes, and recombinant growth factors. Advances in bioengineering are facilitating the replacement of natural materials with recombinant proteins and synthetic peptides to enhance stability and consistency. Within the supply chain, biological safety and purification standards are critical quality control points, with materials required to meet pharmacopeia and GMP criteria. In the future, as sourcing transitions from animal tissues to synthetic biology and serum-free systems, product uniformity and cost efficiency are expected to improve significantly.

This report aims to provide a comprehensive presentation of the global market for Regenerative Biologic Injectables, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Regenerative Biologic Injectables.

The Regenerative Biologic Injectables market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Regenerative Biologic Injectables market comprehensively. Regional market sizes, concerning products by Type, by Application, by Therapeutic Application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Regenerative Biologic Injectables companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Regenerative Biologic Injectables Market Report

Report Metric	Details
Report Name	Regenerative Biologic Injectables Market
Accounted market size in year	US$ 20154 million
Forecasted market size in 2031	US$ 40806 million
CAGR	10.7%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Platelet-Rich Plasma (PRP) Autologous Cell/BMAC/Stem-Cell Derived Amniotic/Placental Allografts Other
Segment by Therapeutic Application	Orthopedics & MSK Aesthetics/Anti-Aging Wound & Ulcer Care Other
Segment by Source of Material	Autologous Allogeneic Xenogeneic
Segment by Application	Hospital Clinic Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Arthrex, Stryker, Zimmer Biomet, EmCyte, Regen Lab, Applied Biologics, Smith+Nephew, Organogenesis, MiMedx, Celularity
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Therapeutic Application etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Regenerative Biologic Injectables company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Regenerative Biologic Injectables Market growing?

Ans: The Regenerative Biologic Injectables Market witnessing a CAGR of 10.7% during the forecast period 2025-2031.

What is the Regenerative Biologic Injectables Market size in 2031?

Ans: The Regenerative Biologic Injectables Market size in 2031 will be US$ 40806 million.

Who are the main players in the Regenerative Biologic Injectables Market report?

Ans: The main players in the Regenerative Biologic Injectables Market are Arthrex, Stryker, Zimmer Biomet, EmCyte, Regen Lab, Applied Biologics, Smith+Nephew, Organogenesis, MiMedx, Celularity

What are the Application segmentation covered in the Regenerative Biologic Injectables Market report?

Ans: The Applications covered in the Regenerative Biologic Injectables Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Regenerative Biologic Injectables Market report?

Ans: The Types covered in the Regenerative Biologic Injectables Market report are Platelet-Rich Plasma (PRP), Autologous Cell/BMAC/Stem-Cell Derived, Amniotic/Placental Allografts, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Regenerative Biologic Injectables Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Platelet-Rich Plasma (PRP)

1.2.3 Autologous Cell/BMAC/Stem-Cell Derived

1.2.4 Amniotic/Placental Allografts

1.2.5 Other

1.3 Market by Therapeutic Application

1.3.1 Global Regenerative Biologic Injectables Market Size Growth Rate by Therapeutic Application: 2020 VS 2024 VS 2031

1.3.2 Orthopedics & MSK

1.3.3 Aesthetics/Anti-Aging

1.3.4 Wound & Ulcer Care

1.3.5 Other

1.4 Market by Source of Material

1.4.1 Global Regenerative Biologic Injectables Market Size Growth Rate by Source of Material: 2020 VS 2024 VS 2031

1.4.2 Autologous

1.4.3 Allogeneic

1.4.4 Xenogeneic

1.5 Market by Application

1.5.1 Global Regenerative Biologic Injectables Market Growth by Application: 2020 VS 2024 VS 2031

1.5.2 Hospital

1.5.3 Clinic

1.5.4 Other

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global Regenerative Biologic Injectables Market Perspective (2020-2031)

2.2 Global Regenerative Biologic Injectables Growth Trends by Region

2.2.1 Global Regenerative Biologic Injectables Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Regenerative Biologic Injectables Historic Market Size by Region (2020-2025)

2.2.3 Regenerative Biologic Injectables Forecasted Market Size by Region (2026-2031)

2.3 Regenerative Biologic Injectables Market Dynamics

2.3.1 Regenerative Biologic Injectables Industry Trends

2.3.2 Regenerative Biologic Injectables Market Drivers

2.3.3 Regenerative Biologic Injectables Market Challenges

2.3.4 Regenerative Biologic Injectables Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Regenerative Biologic Injectables Players by Revenue

3.1.1 Global Top Regenerative Biologic Injectables Players by Revenue (2020-2025)

3.1.2 Global Regenerative Biologic Injectables Revenue Market Share by Players (2020-2025)

3.2 Global Top Regenerative Biologic Injectables Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Regenerative Biologic Injectables Revenue

3.4 Global Regenerative Biologic Injectables Market Concentration Ratio

3.4.1 Global Regenerative Biologic Injectables Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Regenerative Biologic Injectables Revenue in 2024

3.5 Global Key Players of Regenerative Biologic Injectables Head office and Area Served

3.6 Global Key Players of Regenerative Biologic Injectables, Product and Application

3.7 Global Key Players of Regenerative Biologic Injectables, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Regenerative Biologic Injectables Breakdown Data by Type

4.1 Global Regenerative Biologic Injectables Historic Market Size by Type (2020-2025)

4.2 Global Regenerative Biologic Injectables Forecasted Market Size by Type (2026-2031)

5 Regenerative Biologic Injectables Breakdown Data by Application

5.1 Global Regenerative Biologic Injectables Historic Market Size by Application (2020-2025)

5.2 Global Regenerative Biologic Injectables Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Regenerative Biologic Injectables Market Size (2020-2031)

6.2 North America Regenerative Biologic Injectables Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Regenerative Biologic Injectables Market Size by Country (2020-2025)

6.4 North America Regenerative Biologic Injectables Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Regenerative Biologic Injectables Market Size (2020-2031)

7.2 Europe Regenerative Biologic Injectables Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Regenerative Biologic Injectables Market Size by Country (2020-2025)

7.4 Europe Regenerative Biologic Injectables Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Regenerative Biologic Injectables Market Size (2020-2031)

8.2 Asia-Pacific Regenerative Biologic Injectables Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Regenerative Biologic Injectables Market Size by Region (2020-2025)

8.4 Asia-Pacific Regenerative Biologic Injectables Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Regenerative Biologic Injectables Market Size (2020-2031)

9.2 Latin America Regenerative Biologic Injectables Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Regenerative Biologic Injectables Market Size by Country (2020-2025)

9.4 Latin America Regenerative Biologic Injectables Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Regenerative Biologic Injectables Market Size (2020-2031)

10.2 Middle East & Africa Regenerative Biologic Injectables Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Regenerative Biologic Injectables Market Size by Country (2020-2025)

10.4 Middle East & Africa Regenerative Biologic Injectables Market Size by Country (2026-2031)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Arthrex

11.1.1 Arthrex Company Details

11.1.2 Arthrex Business Overview

11.1.3 Arthrex Regenerative Biologic Injectables Introduction

11.1.4 Arthrex Revenue in Regenerative Biologic Injectables Business (2020-2025)

11.1.5 Arthrex Recent Development

11.2 Stryker

11.2.1 Stryker Company Details

11.2.2 Stryker Business Overview

11.2.3 Stryker Regenerative Biologic Injectables Introduction

11.2.4 Stryker Revenue in Regenerative Biologic Injectables Business (2020-2025)

11.2.5 Stryker Recent Development

11.3 Zimmer Biomet

11.3.1 Zimmer Biomet Company Details

11.3.2 Zimmer Biomet Business Overview

11.3.3 Zimmer Biomet Regenerative Biologic Injectables Introduction

11.3.4 Zimmer Biomet Revenue in Regenerative Biologic Injectables Business (2020-2025)

11.3.5 Zimmer Biomet Recent Development

11.4 EmCyte

11.4.1 EmCyte Company Details

11.4.2 EmCyte Business Overview

11.4.3 EmCyte Regenerative Biologic Injectables Introduction

11.4.4 EmCyte Revenue in Regenerative Biologic Injectables Business (2020-2025)

11.4.5 EmCyte Recent Development

11.5 Regen Lab

11.5.1 Regen Lab Company Details

11.5.2 Regen Lab Business Overview

11.5.3 Regen Lab Regenerative Biologic Injectables Introduction

11.5.4 Regen Lab Revenue in Regenerative Biologic Injectables Business (2020-2025)

11.5.5 Regen Lab Recent Development

11.6 Applied Biologics

11.6.1 Applied Biologics Company Details

11.6.2 Applied Biologics Business Overview

11.6.3 Applied Biologics Regenerative Biologic Injectables Introduction

11.6.4 Applied Biologics Revenue in Regenerative Biologic Injectables Business (2020-2025)

11.6.5 Applied Biologics Recent Development

11.7 Smith+Nephew

11.7.1 Smith+Nephew Company Details

11.7.2 Smith+Nephew Business Overview

11.7.3 Smith+Nephew Regenerative Biologic Injectables Introduction

11.7.4 Smith+Nephew Revenue in Regenerative Biologic Injectables Business (2020-2025)

11.7.5 Smith+Nephew Recent Development

11.8 Organogenesis

11.8.1 Organogenesis Company Details

11.8.2 Organogenesis Business Overview

11.8.3 Organogenesis Regenerative Biologic Injectables Introduction

11.8.4 Organogenesis Revenue in Regenerative Biologic Injectables Business (2020-2025)

11.8.5 Organogenesis Recent Development

11.9 MiMedx

11.9.1 MiMedx Company Details

11.9.2 MiMedx Business Overview

11.9.3 MiMedx Regenerative Biologic Injectables Introduction

11.9.4 MiMedx Revenue in Regenerative Biologic Injectables Business (2020-2025)

11.9.5 MiMedx Recent Development

11.10 Celularity

11.10.1 Celularity Company Details

11.10.2 Celularity Business Overview

11.10.3 Celularity Regenerative Biologic Injectables Introduction

11.10.4 Celularity Revenue in Regenerative Biologic Injectables Business (2020-2025)

11.10.5 Celularity Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Regenerative Biologic Injectables Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Platelet-Rich Plasma (PRP)

Table 3. Key Players of Autologous Cell/BMAC/Stem-Cell Derived

Table 4. Key Players of Amniotic/Placental Allografts

Table 5. Key Players of Other

Table 6. Global Regenerative Biologic Injectables Market Size Growth Rate by Therapeutic Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Key Players of Orthopedics & MSK

Table 8. Key Players of Aesthetics/Anti-Aging

Table 9. Key Players of Wound & Ulcer Care

Table 10. Key Players of Other

Table 11. Global Regenerative Biologic Injectables Market Size Growth Rate by Source of Material (US$ Million): 2020 VS 2024 VS 2031

Table 12. Key Players of Autologous

Table 13. Key Players of Allogeneic

Table 14. Key Players of Xenogeneic

Table 15. Global Regenerative Biologic Injectables Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 16. Global Regenerative Biologic Injectables Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Regenerative Biologic Injectables Market Size by Region (2020-2025) & (US$ Million)

Table 18. Global Regenerative Biologic Injectables Market Share by Region (2020-2025)

Table 19. Global Regenerative Biologic Injectables Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 20. Global Regenerative Biologic Injectables Market Share by Region (2026-2031)

Table 21. Regenerative Biologic Injectables Market Trends

Table 22. Regenerative Biologic Injectables Market Drivers

Table 23. Regenerative Biologic Injectables Market Challenges

Table 24. Regenerative Biologic Injectables Market Restraints

Table 25. Global Regenerative Biologic Injectables Revenue by Players (2020-2025) & (US$ Million)

Table 26. Global Regenerative Biologic Injectables Market Share by Players (2020-2025)

Table 27. Global Top Regenerative Biologic Injectables Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Regenerative Biologic Injectables as of 2024)

Table 28. Ranking of Global Top Regenerative Biologic Injectables Companies by Revenue (US$ Million) in 2024

Table 29. Global 5 Largest Players Market Share by Regenerative Biologic Injectables Revenue (CR5 and HHI) & (2020-2025)

Table 30. Global Key Players of Regenerative Biologic Injectables, Headquarters and Area Served

Table 31. Global Key Players of Regenerative Biologic Injectables, Product and Application

Table 32. Global Key Players of Regenerative Biologic Injectables, Date of Enter into This Industry

Table 33. Mergers & Acquisitions, Expansion Plans

Table 34. Global Regenerative Biologic Injectables Market Size by Type (2020-2025) & (US$ Million)

Table 35. Global Regenerative Biologic Injectables Revenue Market Share by Type (2020-2025)

Table 36. Global Regenerative Biologic Injectables Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 37. Global Regenerative Biologic Injectables Revenue Market Share by Type (2026-2031)

Table 38. Global Regenerative Biologic Injectables Market Size by Application (2020-2025) & (US$ Million)

Table 39. Global Regenerative Biologic Injectables Revenue Market Share by Application (2020-2025)

Table 40. Global Regenerative Biologic Injectables Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 41. Global Regenerative Biologic Injectables Revenue Market Share by Application (2026-2031)

Table 42. North America Regenerative Biologic Injectables Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. North America Regenerative Biologic Injectables Market Size by Country (2020-2025) & (US$ Million)

Table 44. North America Regenerative Biologic Injectables Market Size by Country (2026-2031) & (US$ Million)

Table 45. Europe Regenerative Biologic Injectables Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Europe Regenerative Biologic Injectables Market Size by Country (2020-2025) & (US$ Million)

Table 47. Europe Regenerative Biologic Injectables Market Size by Country (2026-2031) & (US$ Million)

Table 48. Asia-Pacific Regenerative Biologic Injectables Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 49. Asia-Pacific Regenerative Biologic Injectables Market Size by Region (2020-2025) & (US$ Million)

Table 50. Asia-Pacific Regenerative Biologic Injectables Market Size by Region (2026-2031) & (US$ Million)

Table 51. Latin America Regenerative Biologic Injectables Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 52. Latin America Regenerative Biologic Injectables Market Size by Country (2020-2025) & (US$ Million)

Table 53. Latin America Regenerative Biologic Injectables Market Size by Country (2026-2031) & (US$ Million)

Table 54. Middle East & Africa Regenerative Biologic Injectables Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 55. Middle East & Africa Regenerative Biologic Injectables Market Size by Country (2020-2025) & (US$ Million)

Table 56. Middle East & Africa Regenerative Biologic Injectables Market Size by Country (2026-2031) & (US$ Million)

Table 57. Arthrex Company Details

Table 58. Arthrex Business Overview

Table 59. Arthrex Regenerative Biologic Injectables Product

Table 60. Arthrex Revenue in Regenerative Biologic Injectables Business (2020-2025) & (US$ Million)

Table 61. Arthrex Recent Development

Table 62. Stryker Company Details

Table 63. Stryker Business Overview

Table 64. Stryker Regenerative Biologic Injectables Product

Table 65. Stryker Revenue in Regenerative Biologic Injectables Business (2020-2025) & (US$ Million)

Table 66. Stryker Recent Development

Table 67. Zimmer Biomet Company Details

Table 68. Zimmer Biomet Business Overview

Table 69. Zimmer Biomet Regenerative Biologic Injectables Product

Table 70. Zimmer Biomet Revenue in Regenerative Biologic Injectables Business (2020-2025) & (US$ Million)

Table 71. Zimmer Biomet Recent Development

Table 72. EmCyte Company Details

Table 73. EmCyte Business Overview

Table 74. EmCyte Regenerative Biologic Injectables Product

Table 75. EmCyte Revenue in Regenerative Biologic Injectables Business (2020-2025) & (US$ Million)

Table 76. EmCyte Recent Development

Table 77. Regen Lab Company Details

Table 78. Regen Lab Business Overview

Table 79. Regen Lab Regenerative Biologic Injectables Product

Table 80. Regen Lab Revenue in Regenerative Biologic Injectables Business (2020-2025) & (US$ Million)

Table 81. Regen Lab Recent Development

Table 82. Applied Biologics Company Details

Table 83. Applied Biologics Business Overview

Table 84. Applied Biologics Regenerative Biologic Injectables Product

Table 85. Applied Biologics Revenue in Regenerative Biologic Injectables Business (2020-2025) & (US$ Million)

Table 86. Applied Biologics Recent Development

Table 87. Smith+Nephew Company Details

Table 88. Smith+Nephew Business Overview

Table 89. Smith+Nephew Regenerative Biologic Injectables Product

Table 90. Smith+Nephew Revenue in Regenerative Biologic Injectables Business (2020-2025) & (US$ Million)

Table 91. Smith+Nephew Recent Development

Table 92. Organogenesis Company Details

Table 93. Organogenesis Business Overview

Table 94. Organogenesis Regenerative Biologic Injectables Product

Table 95. Organogenesis Revenue in Regenerative Biologic Injectables Business (2020-2025) & (US$ Million)

Table 96. Organogenesis Recent Development

Table 97. MiMedx Company Details

Table 98. MiMedx Business Overview

Table 99. MiMedx Regenerative Biologic Injectables Product

Table 100. MiMedx Revenue in Regenerative Biologic Injectables Business (2020-2025) & (US$ Million)

Table 101. MiMedx Recent Development

Table 102. Celularity Company Details

Table 103. Celularity Business Overview

Table 104. Celularity Regenerative Biologic Injectables Product

Table 105. Celularity Revenue in Regenerative Biologic Injectables Business (2020-2025) & (US$ Million)

Table 106. Celularity Recent Development

Table 107. Research Programs/Design for This Report

Table 108. Key Data Information from Secondary Sources

Table 109. Key Data Information from Primary Sources

Table 110. Authors List of This Report

List of Figures

Figure 1. Regenerative Biologic Injectables Picture

Figure 2. Global Regenerative Biologic Injectables Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Regenerative Biologic Injectables Market Share by Type: 2024 VS 2031

Figure 4. Platelet-Rich Plasma (PRP) Features

Figure 5. Autologous Cell/BMAC/Stem-Cell Derived Features

Figure 6. Amniotic/Placental Allografts Features

Figure 7. Other Features

Figure 8. Global Regenerative Biologic Injectables Market Size Comparison by Therapeutic Application (2020-2031) & (US$ Million)

Figure 9. Orthopedics & MSK Features

Figure 10. Aesthetics/Anti-Aging Features

Figure 11. Wound & Ulcer Care Features

Figure 12. Other Features

Figure 13. Global Regenerative Biologic Injectables Market Size Comparison by Source of Material (2020-2031) & (US$ Million)

Figure 14. Autologous Features

Figure 15. Allogeneic Features

Figure 16. Xenogeneic Features

Figure 17. Global Regenerative Biologic Injectables Market Size by Application (2020-2031) & (US$ Million)

Figure 18. Global Regenerative Biologic Injectables Market Share by Application: 2024 VS 2031

Figure 19. Hospital Case Studies

Figure 20. Clinic Case Studies

Figure 21. Other Case Studies

Figure 22. Regenerative Biologic Injectables Report Years Considered

Figure 23. Global Regenerative Biologic Injectables Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 24. Global Regenerative Biologic Injectables Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 25. Global Regenerative Biologic Injectables Market Share by Region: 2024 VS 2031

Figure 26. Global Regenerative Biologic Injectables Market Share by Players in 2024

Figure 27. Global Regenerative Biologic Injectables Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 28. The Top 10 and 5 Players Market Share by Regenerative Biologic Injectables Revenue in 2024

Figure 29. North America Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. North America Regenerative Biologic Injectables Market Share by Country (2020-2031)

Figure 31. United States Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Canada Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Europe Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Europe Regenerative Biologic Injectables Market Share by Country (2020-2031)

Figure 35. Germany Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. France Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. U.K. Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Italy Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Russia Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Ireland Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Asia-Pacific Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Asia-Pacific Regenerative Biologic Injectables Market Share by Region (2020-2031)

Figure 43. China Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Japan Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. South Korea Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Southeast Asia Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. India Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Australia & New Zealand Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Latin America Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Latin America Regenerative Biologic Injectables Market Share by Country (2020-2031)

Figure 51. Mexico Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Brazil Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Middle East & Africa Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 54. Middle East & Africa Regenerative Biologic Injectables Market Share by Country (2020-2031)

Figure 55. Israel Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 56. Saudi Arabia Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 57. UAE Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 58. Arthrex Revenue Growth Rate in Regenerative Biologic Injectables Business (2020-2025)

Figure 59. Stryker Revenue Growth Rate in Regenerative Biologic Injectables Business (2020-2025)

Figure 60. Zimmer Biomet Revenue Growth Rate in Regenerative Biologic Injectables Business (2020-2025)

Figure 61. EmCyte Revenue Growth Rate in Regenerative Biologic Injectables Business (2020-2025)

Figure 62. Regen Lab Revenue Growth Rate in Regenerative Biologic Injectables Business (2020-2025)

Figure 63. Applied Biologics Revenue Growth Rate in Regenerative Biologic Injectables Business (2020-2025)

Figure 64. Smith+Nephew Revenue Growth Rate in Regenerative Biologic Injectables Business (2020-2025)

Figure 65. Organogenesis Revenue Growth Rate in Regenerative Biologic Injectables Business (2020-2025)

Figure 66. MiMedx Revenue Growth Rate in Regenerative Biologic Injectables Business (2020-2025)

Figure 67. Celularity Revenue Growth Rate in Regenerative Biologic Injectables Business (2020-2025)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions